Centessa Pharmaceuticals-adr (CNTA)

$9.93

+0.39

(+4.09%)

Market is closed - opens 7 PM, 17 Jul 2024

Performance

  • $9.54
    $9.99
    $9.93
    downward going graph

    3.93%

    Downside

    Day's Volatility :4.5%

    Upside

    0.6%

    downward going graph
  • $5.15
    $12.45
    $9.93
    downward going graph

    48.14%

    Downside

    52 Weeks Volatility :58.63%

    Upside

    20.24%

    downward going graph

Returns

PeriodCentessa Pharmaceuticals-adrSector (Health Care)Index (Russel 2000)
3 Months
-7.88%
8.2%
0.0%
6 Months
24.75%
7.5%
0.0%
1 Year
25.22%
14.3%
0.0%
3 Years
-53.42%
16.5%
-18.2%

Highlights

Market Capitalization
1.1B
Book Value
$2.14
Earnings Per Share (EPS)
-1.42
Wall Street Target Price
14.2
Profit Margin
0.0%
Operating Margin TTM
-2312.8%
Return On Assets TTM
-27.06%
Return On Equity TTM
-54.45%
Revenue TTM
6.9M
Revenue Per Share TTM
0.07
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-158.1M
Diluted Eps TTM
-1.42
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.69
EPS Estimate Next Year
-1.74
EPS Estimate Current Quarter
-0.42
EPS Estimate Next Quarter
-0.45

Analyst Recommendation

Buy
    81%Buy
    18%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Centessa Pharmaceuticals-adr(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 43.0%

Current $9.93
Target $14.20

Technicals Summary

Sell

Neutral

Buy

Centessa Pharmaceuticals-adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Centessa Pharmaceuticals-adr
Centessa Pharmaceuticals-adr
4.2%
24.75%
25.22%
-53.42%
-54.72%
Moderna, Inc.
Moderna, Inc.
-9.25%
24.7%
2.07%
-60.09%
791.95%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
4.75%
17.85%
51.74%
87.1%
265.7%
Novo Nordisk A/s
Novo Nordisk A/s
0.36%
32.05%
75.05%
218.96%
483.19%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.23%
12.73%
36.59%
145.42%
176.04%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Centessa Pharmaceuticals-adr
Centessa Pharmaceuticals-adr
NA
NA
NA
-1.69
-0.54
-0.27
NA
2.14
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.94
31.94
1.46
44.22
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
48.76
48.76
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
17.07
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Centessa Pharmaceuticals-adr
Centessa Pharmaceuticals-adr
Buy
$1.1B
-54.72%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$48.0B
791.95%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$119.2B
265.7%
31.94
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$633.1B
483.19%
48.76
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
176.04%
31.85
39.46%

Insights on Centessa Pharmaceuticals-adr

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 75.0% return, outperforming this stock by 49.8%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 217.8% return, outperforming this stock by 270.7%

Institutional Holdings

  • Medicxi Ventures Management (Jersey) Ltd

    17.66%
  • General Atlantic Llc

    8.56%
  • EcoR1 Capital, LLC

    4.97%
  • Vida Ventures Advisors, LLC

    3.48%
  • Perceptive Advisors LLC

    2.73%
  • First Light Asset Management, LLC

    2.66%

Company Information

centessa pharmaceuticals plc is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. the company applies an asset-centric r&d model at scale to advance a portfolio of highly validated programs led by industry leading teams. each program is developed by a centessa subsidiary and supported by a centralized infrastructure and the centessa management team. the company is headquartered in cambridge, mass.

Organization
Centessa Pharmaceuticals-adr
Employees
77
CEO
Dr. Saurabh Saha M.D., Ph.D.
Industry
Healthcare

FAQs